while waiting for the conference to start. I started re-watching the interview from last year.
at minute 11:30, the Prof explains that Rex held an RMAT designation and how the FDA might 'OK' with our DREAM HF trial. Hopefully luck is on MSB's side this year. All LTSH have been smashed for a long time now.
At ~14:40 the Prof explain that Rex reduce hospitalization from ischemic events by 3-4 folds, BUT NOT hospitalization by volume overload @DocMcstuffins, then went on to explain his theory.
while waiting for the conference to start. I started re-watching...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.030(2.73%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.21 | $1.05 | $28.73M | 25.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14264 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 24626 | 3 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
-0.030 ( 2.52 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.21 | $1.05 | 5190842 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| MSB (ASX) Chart |